期刊文献+

细胞增殖法检测注射用特立帕肽生物活性方法的建立和验证 被引量:3

Establishment and validation of the method for determination of biological activity of teriparatide for injection by cell proliferation test
原文传递
导出
摘要 目的:建立并验证检测注射用特立帕肽生物活性的细胞增殖法。方法:采用MC3T3-E1细胞增殖法检测不同浓度注射用特立帕肽的生物活性,通过检测特异性拮抗剂TIP-39对特立帕肽促MC3T3-E1细胞增殖的抑制作用以验证方法的专属性,同时验证方法的重复性、线性和检测范围并用确立的方法将不同批次的注射用特立帕肽与上市对照品进行活性对比。结果:建立的细胞增殖法专属性和重复性良好,有效检测范围是1.25~80 nmol.L-1,促增殖活性为20%~85%,线性相关系数=0.989 8,且自制注射用特立帕肽活性与上市对照品一致。结论:建立的细胞增殖法能有效用于注射用特立帕肽的体外生物活性测定。 OBJECTIVE To establish and validate the cell proliferation test for detecting the biological activity of teriparatide for injection.METHODS MC3T3-E1 cell proliferation test was used for detecting biological activity of teriparatide for injection in different concentration.The specificity investigation of teriparatide stimulating MC3T3-E1 cell proliferation was demonstrated by adding the specific inhibitor TIP-39.Reproducibility,linear and range of this method were validated and the activity consistency evaluation of different teriparatide batches with launched product was implemented.RESULTS The cell proliferation test had good specificity and reproducibility and the detection range was from 1.25 to 80 nmol·L-1,the biological activity range of teriparatide was from 20% to 85%,the linear correlation coefficient was 0.9898.Furthermore,the biological activity of domestic produced teriparatide for injection was consistent with launched product.CONCLUSION The established method can be applied to the activity determination of teriparatide for injection in vitro effectively.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第17期1392-1395,共4页 Chinese Journal of Hospital Pharmacy
基金 海南省高新技术项目(编号:2012201)
关键词 注射用特立帕肽 MC3T3-E1细胞 细胞增殖法 生物活性 teriparatide for injection MC3T3-E1 cell cell proliferation test biological activity
  • 相关文献

参考文献13

  • 1徐娟,王林.礼莱公司的特立帕肽首次获得批准[J],Foreign Medical Sciences Section on Pharmacy,2003,30(3):192.
  • 2Keutmann HT, Griscom AW, Nussbaum SR, etal. Rat para thyroid hormone-(1-34) fragment: renal adenylate cyclase ac tivity and receptor binding properties in vitro[J]. Endocrinolo- gy, 1985, 117(3): 1230-1234.
  • 3熊元,熊霞辉,卢雅彬,朱宁,陈梅红.Tmed2促进体外小鼠前成骨细胞MC3T3-E1增殖[J].基础医学与临床,2012,32(7):751-755. 被引量:1
  • 4药品审评中心.生物制品质量控制分析方法验证技术审评一般原则[S].2005,12:1.
  • 5岳云飞,张丽英.MTT法测定注射用鹿瓜多肽活性[J].黑龙江医药,2011,24(3):348-349. 被引量:3
  • 6李萍,陆俭,马亚茹,应莲芳,蒋琳.细胞增殖法检测rhCNTF生物活性方法的建立和验证[J].药物生物技术,2012,19(1):55-59. 被引量:4
  • 7Skripitz R, Andreassen TT, Aspenberg P. Parathyroid hor-mone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study[J]. J Bone Joint Surg Br, 2000, 82(1): 138-141.
  • 8Jonsson KB, John MR, Gensure RC, et al. Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH- related peptide receptor, but functions as an antagonist[J]. Endocrinology, 2001, 142(2): 704-709.
  • 9于婷,宋小红,付玲,侯利华.TF-1细胞增殖法测定神经生长因子生物学活性的建立与应用[J].生物技术通讯,2012,23(6):840-845. 被引量:8
  • 10Seitz PK, Nickols GA, Nickols MA, et al, Cooper CW. Ra- dioiodinated rat parathyroid hormone-(1-34) binds to its receptor on rat osteosarcoma cells in a manner consistent with two classes of binding sites[J]. J Bone Miner Res, 1990, 5 (4): 353 359.

二级参考文献42

  • 1沈世烨.TF-1细胞饥饿在IL-4生物学活性测定中的应用[J].海峡药学,2006,18(5):69-70. 被引量:1
  • 2毕华,袁力勇,史新昌,赵阳,刘兰,饶春明,王军志.睫状神经营养因子突变体蛋白的活性研究[J].中国生物工程杂志,2007,27(1):1-5. 被引量:10
  • 3国家药品标准第九册[S].
  • 4应莲芳,雷清,梁凌宇,高雪峰,蒋琳.重组人睫状神经营养因子突变体的构建、表达及生物活性分析[J].生物技术,2007,17(4):16-18. 被引量:6
  • 5Aylwin S, A1-Zaman Y. Emerging concepts in the medical and surgical treatment of obesity[ Jl. Front Hom Res ,2008,36:229.
  • 6Liu QS, GaoM, Zhu SY, et al. The novel mechanism of recombinant human ciliary neurotrophic factor on the anti-diabetes activity [ J ]. Basic Clin Pharmacol Toxicol,2007,101 (2) :78.
  • 7Hockmann K, Ball AK. CNTF Enhances Axon Regeneration and Survival of Retinal Ganglion Ceils After ET-1 Treatment [ J ]. Invest Ophthalmol Vis Sci,2005:46.
  • 8Lambert P D,Anderson K D,Sleeman M W,et al. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even inleptin-resistant obesity[J]. Proc Natl Acta Sci USA,2001,98(8) :4652.
  • 9Vacher CM, Crep in D, AubourgA, et al. A putative physiological role of hypothalamic CNTF in the control of energy homeostasis [J]. FEBS Lett ,2008,582 ( 27 ) :3832.
  • 10Cota D, Matter E K, Woods SC, et al. The role of hypothalamic mammalian target of rapamycin complex 1 signaling indictinduced obesity[J]. J Neurosci ,2008,28( 28 ) :7202.

共引文献24

同被引文献38

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部